Table 1.
Correlation between immunohistochemistry staining intensity for DDX56 and clinicopathological features in 30 GC patients.
| DDX56 expression |
|||||
|---|---|---|---|---|---|
| Characteristics | Case | Low | High | p-value | |
| Age (years) | |||||
| <60 | 18 | 7 | 11 | 1.000 | |
| ≥60 | 12 | 4 | 8 | ||
| Gender | |||||
| Male | 19 | 7 | 12 | 1.000 | |
| Female | 11 | 4 | 7 | ||
| Tumor size (cm) | |||||
| ≥5 | 11 | 2 | 9 | 0.140 | |
| <5 | 19 | 9 | 10 | ||
| Tumor site | |||||
| Cardiac | 3 | 1 | 2 | 1.000 | |
| Non-cardiac | 27 | 10 | 17 | ||
| Differentiation | |||||
| PD | 29 | 11 | 18 | 1.000 | |
| MD | 1 | 0 | 1 | ||
| T grade | |||||
| T1 + T2 | 3 | 1 | 2 | 0.501 | |
| T3 + T4 | 27 | 10 | 17 | ||
| Lymph node metastasis | |||||
| Negative (N0) | 8 | 6 | 2 | 0.028# | |
| Positive (N1-N3) | 22 | 5 | 17 | ||
| TNM stage | |||||
| I-II | 7 | 5 | 2 | 0.068 | |
| III-IV | 23 | 6 | 17 | ||
PD, poorly differentiated; MD, moderately differentiated.
#: Significantly different at p < 0.05.